Fibromyalgia – FDA approves Cyclobenzaprine
The FDA has approved cyclobenzaprine hydrochloride sublingual tablets, a first-in-class, non-opioid treatment for adults with fibromyalgia, a chronic pain syndrome that affects more than 10 million Americans, roughly 80% of whom are women. The medication, taken once-daily at bedtime, targets nonrestorative sleep, a root cause Read more








